BLT 0.00% 2.6¢ benitec biopharma limited

Ann: FOURTH SITE IN HEPATITIS C CLINICAL TRIAL, page-7

  1. 2,524 Posts.
    lightbulb Created with Sketch. 69
    I agree, Smokey. The language clearly states that RECRUITMENT and DOSING are proceeding well. One can hardly say that there is delay with that verbiage. Additionally, opening another site just makes the recruitment process easier. I also agree that the language is specifically chosen to "update" but release no specifics on the trial. I think it was a fair way to update the market without reporting as they have in the past, which they specifically said they wouldn't.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.